4833M 15/500 Pill - white oval, 14mm
Generic Name: metformin/pioglitazone
Pill with imprint 4833M 15/500 is White, Oval and has been identified as Actoplus Met 500 mg / 15 mg. It is supplied by Takeda Pharmaceuticals America, Inc.
ActoPlus Met is used in the treatment of Diabetes, Type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met 500 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 4833M 15/500
Actoplus Met
- Generic Name
- metformin/pioglitazone
- Imprint
- 4833M 15/500
- Strength
- 500 mg / 15 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceuticals America, Inc.
- Inactive Ingredients
-
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
hypromellose 2910 (6 mPa.s),
polyethylene glycol 8000,
titanium dioxide,
magnesium silicate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 64764-0155 | Takeda Pharmaceutical Company Limited |
| 00093-5049 (Discontinued) | Teva Pharmaceuticals USA, Inc. |
| 42291-0693 (Discontinued) | AvKare, Inc. |
| 54868-5500 (Discontinued) | Physicians Total Care Inc. (repackager) |
Related images for "4833M 15/500"
More about ActoPlus Met (metformin / pioglitazone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: antidiabetic combinations
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
